JOHN J. MILLER
- Type
- Physician · Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Psychiatry
- Where
- Exeter, NH
- NPI
- 1841307527
- Received
- $2,715,943 in 3,360 records, 2019 to 2025
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 583 | $636,924 |
| 2024 | General payment | 611 | $511,845 |
| 2023 | General payment | 522 | $397,697 |
| 2022 | General payment | 478 | $347,658 |
| 2021 | General payment | 257 | $217,572 |
| 2020 | General payment | 239 | $179,528 |
| 2019 | General payment | 670 | $424,715 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 526 | $478,436 | 2020–2025 |
| Otsuka America Pharmaceutical, Inc. | 615 | $440,853 | 2019–2025 |
| Neurocrine BioSciences, Inc. | 372 | $352,977 | 2019–2025 |
| Teva Pharmaceuticals USA, Inc. | 282 | $325,165 | 2019–2025 |
| Axsome Therapeutics, Inc. | 306 | $318,190 | 2022–2025 |
| E.R. Squibb & Sons, L.L.C. | 183 | $197,441 | 2024–2025 |
| Janssen Pharmaceuticals, Inc | 258 | $174,703 | 2019–2025 |
| Allergan, Inc. | 197 | $141,919 | 2019–2021 |
| ABBVIE INC. | 221 | $132,322 | 2021–2024 |
| Sunovion Pharmaceuticals Inc. | 265 | $131,379 | 2019–2021 |
| Janssen Research & Development, LLC | 15 | $8,336 | 2019 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 14 | $7,141 | 2023–2024 |
| Biogen, Inc. | 4 | $2,700 | 2021 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 12 | $2,687 | 2019–2025 |
| Alkermes, Inc. | 53 | $877 | 2021–2025 |
| Vanda Pharmaceuticals Inc. | 21 | $496 | 2019–2023 |
| Lundbeck LLC | 10 | $183 | 2019–2024 |
| Sage Therapeutics, LLC | 1 | $48 | 2023 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $45 | 2023 |
| JAZZ PHARMACEUTICALS INC. | 1 | $23 | 2024 |
| Janssen Scientific Affairs, LLC | 1 | $12 | 2025 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 716 | $2,049,910 |
| Consulting Fee | 87 | $268,598 |
| Travel and Lodging | 1,307 | $195,286 |
| Honoraria | 28 | $134,329 |
| Food and Beverage | 1,216 | $67,609 |
| Education | 6 | $209 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-23 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $4,440 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-23 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $150 | Travel and Lodging | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-19 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $5,550 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-19 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $4,440 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-15 | E.R. Squibb & Sons, L.L.C. | $4,209 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-12-10 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $119 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-09 | Axsome Therapeutics, Inc. | $3,713 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-12-09 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $2,497 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-09 | Axsome Therapeutics, Inc. | $122 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-12-09 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $33 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-09 | Axsome Therapeutics, Inc. | $19 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-12-09 | Axsome Therapeutics, Inc. | $5 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-12-04 | E.R. Squibb & Sons, L.L.C. | $74 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-12-04 | E.R. Squibb & Sons, L.L.C. | $5 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-12-01 | E.R. Squibb & Sons, L.L.C. | $3,608 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-26 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $212 | Travel and Lodging | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-26 | E.R. Squibb & Sons, L.L.C. | $113 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-25 | E.R. Squibb & Sons, L.L.C. | $9,167 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-11-25 | E.R. Squibb & Sons, L.L.C. | $4,209 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-25 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $91 | Travel and Lodging | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-20 | E.R. Squibb & Sons, L.L.C. | $116 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-19 | E.R. Squibb & Sons, L.L.C. | $2,104 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-18 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $4,440 | Consulting Fee | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-13 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $117 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-13 | Otsuka America Pharmaceutical, Inc. | $20 | Travel and Lodging | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-11-12 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $102 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-11 | E.R. Squibb & Sons, L.L.C. | $121 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-07 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $4,440 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-07 | Otsuka America Pharmaceutical, Inc. | $2,548 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-11-07 | E.R. Squibb & Sons, L.L.C. | $250 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-07 | E.R. Squibb & Sons, L.L.C. | $63 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-06 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $138 | Travel and Lodging | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-06 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $113 | Travel and Lodging | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-06 | E.R. Squibb & Sons, L.L.C. | $10 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-11-04 | Otsuka America Pharmaceutical, Inc. | $121 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-11-03 | Axsome Therapeutics, Inc. | $4,125 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-10-31 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $76 | Travel and Lodging | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-31 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $42 | Food and Beverage | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-31 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $34 | Travel and Lodging | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-31 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $25 | Travel and Lodging | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-30 | E.R. Squibb & Sons, L.L.C. | $122 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-28 | E.R. Squibb & Sons, L.L.C. | $2,404 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-10-28 | Neurocrine BioSciences, Inc. | $2,300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-10-25 | Otsuka Pharmaceutical Development & Commercialization, Inc. | $59 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-10-22 | Otsuka America Pharmaceutical, Inc. | $57 | Travel and Lodging | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-10-22 | Otsuka America Pharmaceutical, Inc. | $23 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-10-22 | Otsuka America Pharmaceutical, Inc. | $20 | Travel and Lodging | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-10-18 | Neurocrine BioSciences, Inc. | $24 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-10-17 | Otsuka America Pharmaceutical, Inc. | $1,960 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-10-17 | Otsuka America Pharmaceutical, Inc. | $134 | Travel and Lodging | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-10-17 | Neurocrine BioSciences, Inc. | $57 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-10-16 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $429 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-16 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $108 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-15 | Otsuka America Pharmaceutical, Inc. | $2,548 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-10-15 | Otsuka America Pharmaceutical, Inc. | $76 | Travel and Lodging | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-10-15 | Otsuka America Pharmaceutical, Inc. | $72 | Travel and Lodging | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-10-15 | Otsuka America Pharmaceutical, Inc. | $34 | Travel and Lodging | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-10-15 | Otsuka America Pharmaceutical, Inc. | $31 | Travel and Lodging | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-10-15 | Otsuka America Pharmaceutical, Inc. | $22 | Travel and Lodging | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-10-15 | Otsuka America Pharmaceutical, Inc. | $19 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-10-10 | Otsuka America Pharmaceutical, Inc. | $4,312 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $868 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $326 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $134 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-09 | Otsuka America Pharmaceutical, Inc. | $133 | Travel and Lodging | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-10-09 | Otsuka America Pharmaceutical, Inc. | $133 | Travel and Lodging | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $64 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $51 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $49 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $29 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $29 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-09 | E.R. Squibb & Sons, L.L.C. | $29 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-10-08 | Otsuka America Pharmaceutical, Inc. | $4,312 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-10-08 | Otsuka America Pharmaceutical, Inc. | $19 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-10-07 | Otsuka America Pharmaceutical, Inc. | $124 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-10-04 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $298 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-04 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $275 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-04 | Otsuka America Pharmaceutical, Inc. | $186 | Travel and Lodging | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-10-04 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $138 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-04 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $59 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-04 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $52 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-04 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $46 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-04 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $44 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-04 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $24 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-04 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $24 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-02 | Otsuka America Pharmaceutical, Inc. | $388 | Travel and Lodging | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-10-02 | Otsuka America Pharmaceutical, Inc. | $105 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-09-29 | Neurocrine BioSciences, Inc. | $1,438 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-09-29 | E.R. Squibb & Sons, L.L.C. | $60 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-09-29 | Otsuka Pharmaceutical Development & Commercialization, Inc. | $44 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-09-26 | Axsome Therapeutics, Inc. | $825 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-09-23 | Axsome Therapeutics, Inc. | $4,125 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-09-23 | Axsome Therapeutics, Inc. | $3,713 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-09-23 | Axsome Therapeutics, Inc. | $1,025 | Travel and Lodging | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-09-23 | Axsome Therapeutics, Inc. | $204 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-09-23 | Axsome Therapeutics, Inc. | $114 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-09-23 | Axsome Therapeutics, Inc. | $106 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-09-23 | Axsome Therapeutics, Inc. | $97 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-09-23 | Axsome Therapeutics, Inc. | $47 | Food and Beverage | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-09-23 | Axsome Therapeutics, Inc. | $42 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-09-23 | Axsome Therapeutics, Inc. | $23 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-09-23 | Axsome Therapeutics, Inc. | $19 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-09-23 | Axsome Therapeutics, Inc. | $18 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-09-23 | Axsome Therapeutics, Inc. | $3 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-09-23 | Axsome Therapeutics, Inc. | $3 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-09-16 | Neurocrine BioSciences, Inc. | $4,600 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-09-16 | Neurocrine BioSciences, Inc. | $3,738 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-09-16 | Neurocrine BioSciences, Inc. | $200 | Travel and Lodging | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-09-16 | Neurocrine BioSciences, Inc. | $127 | Travel and Lodging | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-09-16 | Neurocrine BioSciences, Inc. | $63 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-09-16 | Neurocrine BioSciences, Inc. | $32 | Travel and Lodging | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-09-16 | Neurocrine BioSciences, Inc. | $28 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-09-15 | Neurocrine BioSciences, Inc. | $5,463 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-09-15 | Neurocrine BioSciences, Inc. | $726 | Travel and Lodging | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-09-15 | Neurocrine BioSciences, Inc. | $374 | Travel and Lodging | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-09-15 | Neurocrine BioSciences, Inc. | $68 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-09-12 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $5,550 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-09-12 | E.R. Squibb & Sons, L.L.C. | $3,006 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-09-12 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $77 | Travel and Lodging | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-09-12 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $68 | Travel and Lodging | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-09-12 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $45 | Travel and Lodging | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-09-12 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $38 | Travel and Lodging | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-09-12 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $31 | Travel and Lodging | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-09-12 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $20 | Food and Beverage | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-09-12 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $19 | Food and Beverage | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-09-11 | Axsome Therapeutics, Inc. | $5,363 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-09-11 | Axsome Therapeutics, Inc. | $287 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-09-11 | Axsome Therapeutics, Inc. | $226 | Travel and Lodging | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-09-11 | Axsome Therapeutics, Inc. | $112 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-09-11 | Axsome Therapeutics, Inc. | $99 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-09-11 | Axsome Therapeutics, Inc. | $3 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-09-11 | Axsome Therapeutics, Inc. | $3 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-09-10 | Axsome Therapeutics, Inc. | $5,363 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-09-10 | Axsome Therapeutics, Inc. | $4,125 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-09-10 | Axsome Therapeutics, Inc. | $506 | Travel and Lodging | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-09-10 | Otsuka America Pharmaceutical, Inc. | $158 | Travel and Lodging | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-09-10 | Axsome Therapeutics, Inc. | $120 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-09-10 | Axsome Therapeutics, Inc. | $73 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-09-10 | Axsome Therapeutics, Inc. | $7 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-09-09 | Axsome Therapeutics, Inc. | $5,363 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-09-09 | Axsome Therapeutics, Inc. | $177 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-09-09 | Axsome Therapeutics, Inc. | $115 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-09-09 | Axsome Therapeutics, Inc. | $58 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-09-08 | Axsome Therapeutics, Inc. | $7,013 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-09-08 | Axsome Therapeutics, Inc. | $250 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-09-08 | Axsome Therapeutics, Inc. | $194 | Travel and Lodging | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-09-08 | Axsome Therapeutics, Inc. | $96 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-09-05 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $2,775 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-09-02 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $98 | Travel and Lodging | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-09-02 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $97 | Travel and Lodging | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-09-02 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $34 | Food and Beverage | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-09-02 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $20 | Travel and Lodging | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-08-29 | Otsuka America Pharmaceutical, Inc. | $3,724 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-08-29 | Teva Pharmaceuticals USA, Inc. | $705 | Consulting Fee | Cash or cash equivalent | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-08-29 | Otsuka America Pharmaceutical, Inc. | $112 | Travel and Lodging | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-08-28 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $367 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-08-28 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $232 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-08-28 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $95 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-08-27 | E.R. Squibb & Sons, L.L.C. | $112 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-08-26 | Otsuka America Pharmaceutical, Inc. | $31 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-08-22 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $4,440 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-08-22 | Otsuka America Pharmaceutical, Inc. | $3,724 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-08-21 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $121 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-08-19 | Otsuka America Pharmaceutical, Inc. | $147 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-08-14 | Axsome Therapeutics, Inc. | $5,363 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-14 | Axsome Therapeutics, Inc. | $271 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-14 | Axsome Therapeutics, Inc. | $260 | Travel and Lodging | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-14 | Axsome Therapeutics, Inc. | $125 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-14 | E.R. Squibb & Sons, L.L.C. | $75 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-08-14 | E.R. Squibb & Sons, L.L.C. | $40 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-08-14 | E.R. Squibb & Sons, L.L.C. | $33 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-08-13 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $282 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-08-13 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $128 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-08-12 | E.R. Squibb & Sons, L.L.C. | $2,405 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-08-12 | Janssen Scientific Affairs, LLC | $12 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2025 | |
| 2025-08-11 | Axsome Therapeutics, Inc. | $3,713 | Honoraria | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-11 | Axsome Therapeutics, Inc. | $107 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-11 | Axsome Therapeutics, Inc. | $46 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-11 | Axsome Therapeutics, Inc. | $19 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-11 | Axsome Therapeutics, Inc. | $6 | Travel and Lodging | Cash or cash equivalent | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-07-17 | Neurocrine BioSciences, Inc. | $1,438 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-07-16 | Axsome Therapeutics, Inc. | $104 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-07-07 | E.R. Squibb & Sons, L.L.C. | $3,006 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-07-07 | E.R. Squibb & Sons, L.L.C. | $338 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-07-07 | E.R. Squibb & Sons, L.L.C. | $220 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-07-07 | E.R. Squibb & Sons, L.L.C. | $65 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-07-07 | E.R. Squibb & Sons, L.L.C. | $30 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-07-07 | E.R. Squibb & Sons, L.L.C. | $16 | Travel and Lodging | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-07-03 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $6,660 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-06-27 | Otsuka America Pharmaceutical, Inc. | $877 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-06-27 | Otsuka America Pharmaceutical, Inc. | $21 | Travel and Lodging | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-06-27 | Otsuka America Pharmaceutical, Inc. | $5 | Travel and Lodging | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-06-25 | E.R. Squibb & Sons, L.L.C. | $5,411 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-06-25 | Otsuka America Pharmaceutical, Inc. | $2,548 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-06-25 | Otsuka America Pharmaceutical, Inc. | $198 | Travel and Lodging | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-06-25 | Otsuka America Pharmaceutical, Inc. | $198 | Travel and Lodging | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-06-25 | Otsuka America Pharmaceutical, Inc. | $10 | Travel and Lodging | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-06-18 | Otsuka America Pharmaceutical, Inc. | $125 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-06-17 | E.R. Squibb & Sons, L.L.C. | $95 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-06-14 | Otsuka America Pharmaceutical, Inc. | $4,312 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 |
The latest 200 records of 3,360.
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Exeter, NH, county Rockingham County, NH, state New Hampshire; placed by its city name.
| Measure | Place (city or town) Exeter, NH | County Rockingham County, NH | State New Hampshire |
|---|---|---|---|
| Population B01003 | 9,964 | 319,082 | 1,394,868 |
| Population, 2020 census P1 | 10,109 | 314,176 | 1,377,529 |
| Median age B01002 | 43.8 | 45.0 | 43.3 |
| Under 18 B01001 | 14.7% | 18.5% | 18.2% |
| 65 and over B01001 | 21.9% | 20.4% | 20.1% |
| Households B11001 | 4,529 | 127,570 | 555,822 |
| Foreign born B05002 | 6.3% | 5.2% | 6.1% |
| Median household income B19013 | $87,346 | $118,331 | $99,031 |
| Median family income B19113 | $136,750 | $143,734 | $122,715 |
| Per capita income B19301 | $64,261 | $61,558 | $52,798 |
| Poverty rate B17001 | 5.9% | 4.8% | 7.2% |
| Unemployment rate B23025 | 4.9% | 3.6% | 3.3% |
| Civilian labor force B23025 | 6,368 | 181,426 | 775,826 |
| Mean commute (minutes) B08013 | 24.0 | 28.9 | 26.7 |
| Bachelor's degree or higher B15003 | 57.4% | 45.7% | 40.6% |
| Housing units B25001 | 4,875 | 137,794 | 648,472 |
| Owner-occupied B25003 | 61.7% | 78.4% | 72.8% |
| Renters B25003 | 38.3% | 21.6% | 27.2% |
| Median home value B25077 | $357,500 | $497,500 | $402,500 |
| Median gross rent B25064 | $1,711 | $1,687 | $1,491 |
| White, not Hispanic B03002 | 86.7% | 89.5% | 86.9% |
| Black B03002 | 1.1% | 0.7% | 1.3% |
| Hispanic or Latino B03002 | 3.4% | 3.7% | 4.7% |
| Asian B03002 | 5.1% | 1.9% | 2.6% |
| American Indian and Alaska Native B03002 | 0.0% | 0.1% | 0.1% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Exeter, NH.
Comments